CIDP

What CIDP does

CIDP (Centre International de Développement Pharmaceutique) is an international Contract Research Organisation founded in 2004 in Mauritius as the first CRO in that country, and now operating through four wholly-owned subsidiaries in Mauritius (headquarters, BioPark Phoenix), Romania (Bucharest, est. 2010), India (New Delhi, est. 2011), and Brazil (Rio de Janeiro, est. 2012). The company delivers integrated preclinical and clinical research services for pharmaceutical, medical device, nutraceutical, and cosmetic clients, including BSL-2 laboratory testing using in vitro cell cultures and ex vivo human skin explants, Phase II-IV clinical trial management across therapeutic areas such as diabetes/metabolic disease, dermatology, respiratory, cardiovascular, and pediatrics, plus integral biostatistics, medical writing, and regulatory affairs support. CIDP operates proprietary, peer-reviewed methodologies — notably the Controlled Pollution Exposure System (CPES, 2018) and Blue Light Protection Methodology (2020) — and an in-house Scientific and Technical Committee established in 2017 to drive protocol innovation.

Name

CIDP

Legal name

Centre International de Développement Pharmaceutique (CIDP)

Website

https://cidp-cro.com

Company type

Private

Founded year

2004

Operating status

Operating

Headcount range

51–100 employees

Short description

CIDP is a privately held, Mauritius-headquartered Contract Research Organisation operating across Mauritius, Romania, India, and Brazil, providing preclinical and Phase II-IV clinical research services to pharmaceutical, medical device, nutraceutical, and cosmetic clients worldwide.

Ownership category

akta.pro rank

NAICS

Testing Laboratories and Services (541380)

SIC

Services-Commercial Physical & Biological Research (8731), Services-Testing Laboratories (8734)

akta.pro primary industry

Clinical CROs (Phase I–IV) (HLAGAAAA)

akta.pro secondary industries

Central Laboratory & Clinical Trial Testing CROs (HLAGAAAE), Clinical Data Management, Biostatistics & Statistical Programming CROs (HLAGAAAF), Medical Review & Pharmacovigilance Quality (PV QA/Audits/SOPs) (HLAGALAH)

Keywords

• Contract research services
• Clinical trial management
• Preclinical safety testing
• Cosmetic efficacy studies
• Regulatory affairs support

Headquarters

HQ city

Phoenix

HQ country

Mauritius

HQ region

Africa

Offices4 records

Markets served

GTM type

B2B

Offering type

Services

Revenue model

1. Contract Research Services: CIDP operates as a Contract Research Organization (CRO) providing fee-for-service research contracts to pharmaceutical, medical device, nutraceutical, and cosmetic companies. Services include preclinical testing, clinical trials, regulatory affairs, biostatistics, and medical writing.

Go-to-market motion2 records

Distribution channels1 record

Marketing channels5 records

Core offering

CIDP is a full-service Contract Research Organisation (CRO) providing preclinical and clinical research services to pharmaceutical, medical device, nutraceutical, and cosmetic companies. Services span BSL-2 laboratory testing (in vitro and ex vivo models), Phase II-IV clinical trial management, site management, biostatistics and data management, regulatory affairs, and medical writing, with multi-ethnic volunteer access across Mauritius, Romania, India, and Brazil.

Product overview

CIDP (Centre International de Developpement Pharmaceutique) is a full-service Contract Research Organisation (CRO) offering integrated preclinical and clinical research services. The core portfolio consists of Cosmetic Research (preclinical BSL-2 laboratory testing and clinical safety/efficacy studies) and Pharmaceutical Research (Phase II-IV clinical trials across therapeutic areas including diabetes, respiratory, dermatological, and cardiovascular diseases). These are supported by integral services including Biostatistics & Data Management, Medical Writing, and Regulatory Support. The company operates study centres in Mauritius (headquarters), India, Romania, and Brazil, with over 18,000 preclinical and clinical trials conducted. CIDP is ISO 9001:2015 certified.

Differentiator

Problem solved

Functional benefit

Quantifiable outcome

• 18,000 preclinical and clinical trials successfully completed
• +3 more outcomes

Named customers10 records

Segments4 records

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature5 records

Partnerships

16 partnerships are on record, tiered core and supporting.

• University of MauritiuscoreStrategic or Co-development PartnerAcademic partnership for research collaboration and knowledge exchange in biotechnology and clinical research fields.
• The University of Technology, MauritiuscoreStrategic or Co-development PartnerAcademic collaboration for research projects and talent development in clinical research and pharmaceutical sciences.
• Mauritius Research and Innovation Council (MRIC)coreStrategic or Co-development PartnerPartnership with government research body for innovation initiatives and research development in biotechnology sector.
• Life | Nova+ Diagnostic & LaboratorysupportingTechnology or IntegrationLaboratory diagnostic partnership for enhanced testing capabilities and comprehensive service delivery.
• Maulana Azad Medical CollegecoreStrategic or Co-development PartnerClinical trial partnership with major government medical institution for patient recruitment in complex trials.
• All India Institute of Medical Sciences (AIIMS)coreStrategic or Co-development PartnerCollaboration with premier medical institution for advanced clinical research and specialized patient access.
• Lady Hardinge Medical CollegesupportingStrategic or Co-development PartnerPartnership for clinical trial recruitment and research collaboration in women's and children's health.
• Sir Ganga Ram HospitalsupportingStrategic or Co-development PartnerClinical trial site partnership for patient recruitment in various therapeutic areas.
• Safdarjung HospitalsupportingStrategic or Co-development PartnerGovernment hospital partnership for clinical trial recruitment and research access.
• Action Cancer HospitalsupportingStrategic or Co-development PartnerOncology-focused clinical trial partnership for cancer-related studies.
• BLK HospitalsupportingStrategic or Co-development PartnerMulti-specialty hospital partnership for diverse clinical trial recruitment.
• Regina MariacoreStrategic or Co-development PartnerPartnership with Romania's largest private healthcare network for Phase II, III and IV clinical studies.
• ArensiacoreStrategic or Co-development PartnerPartnership with Romania's largest network of multi-specialty clinics for Phase I studies. Arensia is one of few accredited Phase I centers in Romania.
• Opinion Leaders DermatologistssupportingStrategic or Co-development PartnerCollaboration with key opinion leader dermatologists in medical cabinets and/or at CIDP premises for expert consultation and trial support.
• Dermatologists Specialized in CosmiatrysupportingStrategic or Co-development PartnerPartnership with dermatologists specializing in cosmetic procedures (laser, micro-needling, botox, etc.) for advanced clinical evaluation capabilities.
• Local Farmers (Mauritius)supportingStrategic or Co-development PartnerPartnership with local agricultural producers for access to endemic plants for natural ingredient research and valorization projects.

Scale indicators7 records

Recent moves12 records

Expansion highlights5 records

Broad incumbents

• SGS: Global testing, inspection, and certification company with significant cosmetics and clinical research services. Comparable to CIDP's multi-region testing offering and quality systems (CIDP's former Head of Quality worked at SGS).
• ICON plc: Top-tier global CRO offering Phase I–IV clinical trial services across multiple therapeutic areas. Direct pharma CRO competitor to CIDP, though much larger and more US/EU-centric.
• Medpace: Mid-to-large global CRO focused on Phase II–IV clinical trials across therapeutic areas including dermatology and metabolic disease. Comparable business model to CIDP's pharma side but at materially larger scale.
• Charles River Laboratories: Large global CRO with a strong preclinical and safety-assessment franchise, including skincare/cosmetic testing capacity. Directly comparable to CIDP's BSL-2 lab and preclinical services but at vastly greater scale.
• Intertek: Global testing and quality assurance group with a sizable cosmetic and personal care testing business. Competes with CIDP in cosmetic safety/efficacy testing for global CPG brands.
• Eurofins Scientific: Global testing services group with dedicated cosmetic, clinical, and pharmaceutical testing business lines. Competes with CIDP across cosmetic safety/efficacy and pharma bioanalytical testing.

Emerging players

• Bionos Biological Solutions: European CRO offering in vitro, ex vivo, and clinical testing for cosmetic and pharmaceutical products. Comparable to CIDP's preclinical-to-clinical integrated workflow at a smaller scale.

Direct peers

• proDERM: Specialized dermatological and cosmetic CRO based in Germany, offering clinical efficacy and tolerability studies for skincare and personal care claims — a direct niche competitor to CIDP's cosmetic research business.
• Complife: Italian-headquartered CRO providing regulatory, toxicological, and clinical testing for cosmetics, medical devices, and pharmaceuticals in Europe. Closely comparable to CIDP's integrated cosmetic and pharma preclinical-clinical offering.
• Spincontrol: French cosmetic and clinical evaluation CRO focused on cosmetic, nutraceutical, and pharmaceutical claim substantiation. A direct competitor to CIDP in European cosmetic clinical studies.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat5 records

Key risks6 records

Key highlights7 records

Customer concentration

• YouTubeyoutube.com/user/cidpinternational
• LinkedInlinkedin.com/company/cidp-centre-international-de-developpement-pharmaceutiques
• Facebookfacebook.com/profile.php

Compliance7 records

Revenue estimate

Valuation estimate

Number of profiles

Subsidiaries4 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about CIDP